News + Font Resize -

BMS sells US & Canadian Consumer Medicines Business to Novartis
New York | Monday, September 5, 2005, 08:00 Hrs  [IST]

Bristol-Myers Squibb Company has completed the sale of its US and Canadian Consumer Medicines business to Novartis AG.

As previously disclosed, the transaction includes rights to Bristol-Myers Squibb's US over-the-counter brands in Latin America, Europe, Middle East and Africa. The transfers of these rights are targeted to be completed by the end of the year, said the release.

Post Your Comment

 

Enquiry Form